Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by EquityInveston May 17, 2018 10:31pm
95 Views
Post# 28050258

US Senate Bill 930 - Special Banking Lic for MJ Clients

US Senate Bill 930 - Special Banking Lic for MJ ClientsIt's encouraging to learn that California appreciates the economic impact of Cannabis business - estimated at $10B.  The State is pro-active in supporting this giant industry that a couple of senators sponsored Bill 930 to give special lic to financial institutions with cannabis-business clients.  This will be heard next week, Tuesday.

https://www.sacbee.com/opinion/op-ed/soapbox/article211299184.html

The fact that the global acceptance of cannabis business is at an all time high alleviates some of my anxiety with my ACB holding.  Today was discouraging (an understatement)  I stopped looking at my phone app tracking the shares.  I was miserable at work.

When I got home, I started to eat ice cream to feel better and opened my trading account.  I noticed that my oil stocks are almost all back, they were all down over 30% in early February.  I've given up on them and yet they came back.  This gives me hope that ACB's sp will stage a great come back.  The dilution is real and I am not happy with the acquisition of LEAF.  But it is what it is, may be management sees something that we don't.  There are a lot of unknown in the sector.  This is a new industry - WEED, APH, CRON and ACB are leading the way.  Lots of uncertainties/risks .  The possibilities are endless - partnerships and significant investments from conglomerates, and we can also be bought out as well.

My take is that Canadian legalization will definitely improve our sp and US legalization will bring us significant upside.

Just my thought and wish us all the best of luck.

Bullboard Posts